LAnguage-Motor Imagery Circuits to Improve Motor Learning and Language Comprehension (LAMI)
Recent evidence suggests that cognitive systems do not operate in isolation but interact within broader networks, thus opening new avenues for fundamental and clinical research. An illustrative example is the interaction between language comprehension and motor representations. For instance, motor training (e.g., sports, origami training) can facilitate action verb recognition, whereas motor deficits (e.g., upper limb immobilization) can hinder the processing of action language. Similarly, action language has been shown to affect motor performance. These effects are attributed to an implicit form of motor imagery, an automatic simulation of motor experience (without actual movement) evoked by action words. Interestingly, literature supports the idea that the motor simulations used for imagining an action are also engaged during the reading of action language, leading to similar neurophysiological and behavioral changes in both processes. However, questions remain about the similarity of the simulations generated by motor imagery and action language. This project, encompassing three experimental sequences, aims to address these questions to achieve significant scientific advancements in both theoretical and applied domains.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Laurent VERCUEIL
- Phone Number: 0476765561
- Email: LVercueil@chu-grenoble.fr
Study Contact Backup
- Name: William DUPONT
- Phone Number: +33 (0)6 67 76 00 99
- Email: william.dupont@univ-grenoble-alpes.fr
Study Locations
-
-
-
Dijon, France
- Recruiting
- Université de Bourgogne
-
Contact:
- William DUPONT
- Phone Number: +33 (0)6 67 76 00 99
- Email: william.dupont@univ-grenoble-alpes.fr
-
Contact:
- Florent LEBON
- Phone Number: +33 (0)3 80 39 67 54
- Email: Florent.Lebon@u-bourgogne.fr
-
Principal Investigator:
- Florent LEBON
-
-
Grenob
-
Grenoble, Grenob, France, 38043
- Recruiting
- CHU Grenoble Alpes
-
Principal Investigator:
- Laurent VERCUEIL
-
Contact:
- William DUPONT
- Phone Number: +33 (0)6 67 76 00 99
- Email: william.dupont@univ-grenoble-alpes.fr
-
Contact:
- Laurent VERCUEIL
- Phone Number: +33 (0)4 76 76 55 61
- Email: LVercueil@chu-grenoble.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Subjects will be aged between 18 and 40, reading and understanding French, with no neurological or psychiatric disorders, no uncorrected vision deficits, and meeting all MRI or TMS examination criteria. they were recruited at the University of Burgundy (TMS measures only) and the University of Grenoble Alpes (fMRI measures only).
Description
Inclusion Criteria:
- persons who have given written consent,
- healthy subjects
- subjects reading and understanding French
- right-handed,
- affiliated with a social security system,
- between 18 and 40 years old,
- had completed the TMS inclusion questionnaire or had undergone a medical examination prior to participation in the MRI study.
Exclusion Criteria:
- Existence of a severe general medical condition: cardiac, respiratory, hematological, renal, hepatic, cancerous,
- Regular use of anxiolytics, sedatives, antidepressants, neuroleptics,
- Characterized psychiatric pathology,
- Ingestion of alcohol prior to the examination,
- Persons covered by articles L1121-5 to L1121-8 of the CSP,
- Presence of contraindications to MRI or TMS.
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_CONTROL
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
control group
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
TMS Experimental group
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
fMRI Experimental group
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements Participants were asked to perform arm or foot movements |
|
Experimental ccPAS group
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
Sham ccPAS group
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of corticospinal excitability
Time Frame: 1 hour and 30 minutes
|
this is a physiological response obtained by transcranial magnetic pulses (TMS). This is an indicator of the excitability of the motor system, which can be used at rest or during various cognitive tasks (motor imagery or action reading). |
1 hour and 30 minutes
|
|
Cortical activation (BOLD signal)
Time Frame: 1 hour
|
this is a cortical response obtained via a fMRI. This is an indicator of the brain activity, which can be used at rest or during motor and cognitive tasks (motor imagery or action reading). |
1 hour
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Laurent VERCUEIL, CHU Grenoble Alpes
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 38RC23.0349
- 2023-A02322-43 (Other Identifier: ID RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.